Conjunctivitis in adult patients with moderate‐to‐severe atopic dermatitis: results from five tralokinumab clinical trials
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Conjunctivitis in adult patients with moderate‐to‐severe atopic dermatitis: results from five tralokinumab clinical trials
Authors
Keywords
-
Journal
BRITISH JOURNAL OF DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-10-13
DOI
10.1111/bjd.20810
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis
- (2021) Joseph F. Merola et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis
- (2020) Emma Guttman-Yassky et al. JAMA Dermatology
- Ocular surface disease associated with dupilumab treatment for atopic diseases
- (2020) Canan Asli Utine et al. Ocular Surface
- Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial
- (2020) J.I. Silverberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)
- (2020) A. Wollenberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis
- (2020) Anne-Sofie Halling et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: a propensity score-matched cohort study
- (2020) Maria C. Schneeweiss et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis
- (2020) Roselie Achten et al. Journal of Allergy and Clinical Immunology-In Practice
- ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
- (2020) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis
- (2020) Nina H. Ravn et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
- (2019) D.S. Bakker et al. BRITISH JOURNAL OF DERMATOLOGY
- Atopic dermatitis is an IL-13 dominant disease with greater molecular heterogeneity compared to psoriasis
- (2019) Lam C. Tsoi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
- (2019) Sarah Faiz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Management of dupilumab‐associated conjunctivitis in atopic dermatitis
- (2019) Nora Aszodi et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Conjunctivitis in dupilumab clinical trials
- (2019) B. Akinlade et al. BRITISH JOURNAL OF DERMATOLOGY
- Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
- (2019) J.P. Thyssen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis
- (2019) Thomas Bieber ALLERGY
- Ocular Co-Morbidities of Atopic Dermatitis. Part II: Ocular Disease Secondary to Treatments
- (2019) Kristen M. Beck et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Laboratory safety of dupilumab in moderate‐to‐severe atopic dermatitis: results from three phase III trials ( LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS )
- (2019) A. Wollenberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab‐related conjunctivitis
- (2019) A.N. Voorberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A Clinician’s Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis
- (2019) Gaurav Agnihotri et al. Drugs in research & development
- Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis
- (2019) Ikuo Hirano et al. GASTROENTEROLOGY
- Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?
- (2018) J.P. Thyssen BRITISH JOURNAL OF DERMATOLOGY
- Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
- (2018) Andreas Wollenberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment
- (2018) Andreas Wollenberg et al. Journal of Allergy and Clinical Immunology-In Practice
- Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment
- (2018) Canan Asli Utine et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis
- (2018) Alison D. Treister et al. JAMA Dermatology
- Diagnosis and Management of Conjunctivitis for the Dermatologist
- (2017) Melinda Gooderham et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
- (2017) B. Popovic et al. JOURNAL OF MOLECULAR BIOLOGY
- Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis
- (2017) Jacob P. Thyssen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis
- (2016) Claus Bachert et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now